Neuromyelitis optica (NMOSD): vizsgálatok itt: Görögország
1 trial · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in GörögországClinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- Athens
- Életkor
- 18 év and over
- People
- 40
- Run by
- National and Kapodistrian University of Athens
See details and how to joinNCT06903130